Saltar al contenido

Progyny, Inc. (PGNY) stock: revenue, earnings & dividend

Progyny, Inc. (PGNY, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener PGNY · Nasdaq Gesundheitswesen US-NY

Key figures

Fiscal year
2025
Revenue
1.29 bn $
Revenue growth
10.4 %
Revenue growth 5y (p.a.)
30.2 %
Net income
58.5 m $
Net margin
4.5 %
Operating margin
6.6 %
Earnings per share (diluted)
0.65 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
742 m $
Equity
516 m $
Equity ratio
69.5 %
Return on equity
11.3 %
Cash
112 m $
Operating cash flow
210 m $
Free cash flow
192 m $
Shares outstanding
73,647,334

History

Revenue by fiscal year

2020 345 m $
2021 501 m $
2022 787 m $
2023 1.09 bn $
2024 1.17 bn $
2025 1.29 bn $

Net income by fiscal year

2017 -12.45 m $
2018 661,000 $
2019 -8.57 m $
2020 46.5 m $
2021 65.8 m $
2022 30.4 m $
2023 62 m $
2024 54.3 m $
2025 58.5 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.29 bn $58.5 m $0.65 $–210 m $
20241.17 bn $54.3 m $0.57 $–179 m $
20231.09 bn $62 m $0.62 $–189 m $
2022787 m $30.4 m $0.30 $–80.4 m $
2021501 m $65.8 m $0.66 $–26 m $
2020345 m $46.5 m $0.47 $–36.2 m $
2019–-8.57 m $-0.41 $–-1.53 m $
2018–661,000 $0.04 $–2.27 m $
2017–-12.45 m $-2.37 $–-9.47 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)